1 Ultrasound assessment of fetal cardiac function and risk of adverse obstetric and neonatal outcomes in term fetuses MD (Res) Thesis Dr Gowrishankar Paramasivam CID number: 00681826 Department of Surgery and Cancer Imperial College London -U.K Supervisors: - Professor Phillip Bennett Professor Sailesh Kumar Declaration of originality I declare that this thesis is my original work. I have appropriately referenced where other’s work has been used in my thesis. Copyright declaration “The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution, Non-commercial, No derivatives license. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, they do not use it for commercial purposes and that they do not alter, transform or build upon it. For any reuse or redistribution, researchers must make clear to others about the license terms of this work”
204
Embed
Ultrasound assessment of fetal cardiac function and risk of ...
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
Ultrasound assessment of fetal cardiac function and risk of adverse obstetric
and neonatal outcomes in term fetuses
MD (Res) Thesis
Dr Gowrishankar Paramasivam
CID number: 00681826
Department of Surgery and Cancer
Imperial College
London -U.K
Supervisors: - Professor Phillip Bennett
Professor Sailesh Kumar
Declaration of originality
I declare that this thesis is my original work. I have appropriately referenced where other’s
work has been used in my thesis.
Copyright declaration
“The copyright of this thesis rests with the author and is made available under a Creative
Commons Attribution, Non-commercial, No derivatives license. Researchers are free to copy,
distribute or transmit the thesis on the condition that they attribute it, they do not use it for
commercial purposes and that they do not alter, transform or build upon it. For any reuse or
redistribution, researchers must make clear to others about the license terms of this work”
2
ABSTRACT
Aim: To measure the fetal cardiac output prior to labour and assess the risk of adverse
obstetric and neonatal outcome in singleton pregnancies with appropriately grown for
gestational age (AGA) fetuses at term.
Methods: This was a prospective observational study conducted at Queen Charlotte’s and
Chelsea Hospital, London UK. Fetal cardiac output and fetal cerebro-placental ratio (CPR)
was measured within 72 hours before birth in 200 nulliparous women having singleton
pregnancies with AGA fetuses. Scan details were not available to the clinicians and delivery
was managed per the local protocol and guidelines. Obstetric and neonatal outcomes were
obtained from case notes and were correlated with the ultrasound findings.
Results: Delivery was vaginal in 129 (64.5%) cases and by caesarean section in 71 (35.5%),
including 34 (17.0%) for fetal distress and 37 (18.5%) for failure to progress. Fetuses
delivered by caesarean section for fetal distress, compared to the remaining fetuses, had a
lower median left cardiac output (152.3 vs. 191.7 mL/min/kg; p=0.003), higher difference in
the median ratio between the right to left cardiac output (1.925 vs. 1.340; p=0.002) and
lower CPR (1.222 vs. 1.607; p<0.0001). In screening for emergency caesarean section for
fetal distress, for a 10% false positive rate, the detection rate with the ratio of the right to
the left cardiac output was higher that with the left cardiac output (41% vs. 29%) and with
the CPR (41% vs. 27%). Similarly, the positive predictive value for the ratio of right to left
cardiac output (45%) was higher than for left cardiac output (37%) and for the CPR (35%).
Conclusion: In AGA fetuses at term that develop intrapartum distress, there is evidence of
prelabour redistribution of the cardiac output. The ratio of the right to the left cardiac
output is superior to the left cardiac output and CPR in predicting intrapartum fetal distress.
Such assessments may be useful in stratifying patients for intensity of monitoring during
labour.
3
ACKNOWLEDGEMENTS
I am grateful to my supervisors, Professors Phillip Bennett and Sailesh Kumar, for their
invaluable help and guidance in my research.
I wish to thank the doctors and midwifes in the Department of Obstetrics at Queen
Charlotte’s and Chelsea Hospital for their immense help in recruiting patients and
supporting my research. My special thanks go out to Dr Tom Prior, for his invaluable help
and suggestions during my period of study.
I thank my parents who guided me to take up this noble profession. My wife, the silver
lining of every cloud in my life, has provided her unwavering support and encouragement
during my study; and my children who have accepted the importance of advancing in my
studies even if this was at the expense of time spent with them.
4
STATEMENT OF CANDIDATE CONTRIBUTION
I generated the hypothesis for the studies in this thesis together with my supervisors
Professors Phillip Bennett and Sailesh Kumar. I developed the study design and
methodology with the assistance from my supervisors. I undertook all the ultrasound
assessments, data collection, statistical analysis and wrote this thesis.
5
CONTENTS
Chapter 1 Introduction and literature review 12
1.1 Placental development and fetoplacental circulation:
Impact on fetal growth 14
1.2 Intra partum hypoxia and neural injury 15
1.3 Antenatal and intrapartum assessment of fetal well-being 17
1.4 Role of ultrasound to monitor growth and fetal well-being 20
1.5 Amniotic fluid volume 26
1.6 Meconium stained liquor 28
1.7 Doppler ultrasound in assessment of fetal well-being 29
1.8 Fetal cardiac function 40
1.9 Summary 46
Chapter 2 Methods 47
2.1 Introduction 47
2.2 Aim 47
2.3 Hypothesis 47
2.4 Methods 48
2.5 Ultrasound assessment 49
2.6 Fetal cardiac function 52
2.7 Diastolic function 52
2.8 Systolic function 54
2.9 Left ventricular myocardial performance index (LV-MPI) 56
Chapter 3 Pilot study 58
3.1 Introduction 58
3.2 Aims 58
3.3 Materials and Methods 59
3.4 Results 60
3.5 Discussion 65
6
Chapter 4 Pre-labour assessment of fetal cardiac function 68
4.1 Introduction 68
4.2 Aims 68
4.3 Hypothesis 69
4.4 Methods 69
4.5 Analysis of data 70
4.6 Results 71
4.7 Maternal demographics and ultrasound parameters 75
4.8 Cerebro -placental ratio (CPR) or Cerebro -umbilical ratio (C-U ratio) 78
4.9 Fetal cardiac function 82
4.10 Summary of fetal cardiac function 118
4.11 Amniotic fluid index (AFI) 119
4.12 Deepest vertical pool of liquor (DVP) 120
4.13 Intrapartum monitoring 122
4.14 Neonatal outcomes 124
4.15 Estimated fetal weight (EFW) and outcome 128
Chapter 5 Cardiac functional parameters, cerebroplacental ratio and risk of
adverse obstetric and neonatal outcomes 132
5.1 Maternal demographics and mode of delivery 132
5.2 Maternal demographics and ultrasound parameters 135
5.3 Ethnicity and ultrasound parameters 136
5.4 Cerebro -placental ratio (CPR) 138
5.5 Fetal cardiac functional parameters 140
5.6 Intrapartum and neonatal outcomes 152
Chapter 6 Fetal cardiac function and cerebroplacental ratio in the prediction
of adverse intrapartum outcome 159
6.1 Performance of screening in prediction of intrapartum fetal distress at term 159
7
Chapter 7 Conclusions 163
7.1 Strengths and limitations 163
7.2 Conclusions 167
7.3 Potential clinical application and further research 169
The umbilical artery was the first vessel to be assessed by Doppler velocimetry. The
umbilical artery has a characteristic waveform (saw tooth appearance) with systolic and
diastolic components reflecting the cardiac cycle (Figure 1.3). Sampling is usually performed
at either the fetal end or the placental end of the cord insertion, although impedance
indices are noted to be higher close to the fetal cord insertion.(49)
Figure 1.3: Umbilical artery waveform
With advancing gestation, there is a steady progressive decline, in the end diastolic velocity
resulting in decreased pulsatility indices (Figure 1.4).(50) There are no noticeable diurnal
changes in pregnancy that may affect the umbilical artery blood flow; however, the blood
flow decreases with fetal expiration, and therefore it is preferable to obtain the velocity
assessment during fetal quiescence.
32
Figure 1.4: Umbilical artery Pi. Taken from Parra-Cordero M, Lees C, Harris C. Taken from Fetal arterial and venous Doppler pulsatility index and time averaged velocity ranges. Prenatal Diagnosis 2007; 27: 1251-7
Previously published studies have shown an association with abnormal Umbilical artery
Doppler changes with poor placental function relating to an adverse outcome. The blood
flow resistance in the umbilical arteries is a reflection of increased resistance in the fetal
villous vascular tree and therefore poor placental function results in increased impedance to
the umbilical artery blood flow resulting in absent to reverse end diastolic flow (Figure
1.5).(51) The Cochrane review by Alfirevic et al. in 2007 concluded that use of Doppler
ultrasound in high-risk pregnancies was associated with a reduction in the risk of perinatal
deaths and therefore resulted in less obstetric interventions.(52)
33
Figure 1.5: Umbilical artery Doppler abnormalities. Taken from Baschat AA. Examination of the fetal cardiovascular system. Seminars in Fetal and Neonatal Medicine 2011; 16: 2-12.
While abnormal umbilical artery Doppler waveforms are associated with fetal growth
restriction, studies have also shown that fetuses with abnormal electronic fetal heart rate
monitoring tracing in the intrapartum period are associated with abnormal umbilical artery
waveform evidenced by raised pulsatility indices.(53) Similar studies in combination with
other fetal Doppler and electronic fetal heart rate monitoring were shown to be beneficial
in the evaluation of intrapartum fetal hypoxia.(54)Despite initial observations, subsequent
meta-analysis demonstrated that isolated finding of an abnormal umbilical artery was found
to be a poor predictor of adverse perinatal outcome.(48, 55)
34
Middle cerebral artery
Published studies have demonstrated the changes in Middle cerebral artery (MCA) Doppler
flow and the role of brain sparing in the prediction of adverse outcomes in fetal growth
restriction.(56) The MCA is the vessel of choice in intracranial Doppler assessment due to its
ideal anatomical location which allows the Doppler beam to insonate the vessel close to the
angle of zero degrees (Figure 1.6). There are also studies which have looked at the sampling
site of the vessel, and it is best preferred to sample the MCA proximal to its origin from the
internal carotid artery to decrease inter and intra-observer variability.(57) The MCA Pi usually
peaks from 22 weeks onwards up to until 28 weeks and then continues to show a gradual
decline towards term (Figure 1.8).(58) Growth-restricted fetuses had a decreased pulsatility
index of the MCA due to increased cerebral perfusion (Figure 1.7). Many studies support
that reduced MCA Pi is associated with an adverse perinatal outcome.(59, 60)
Figure 1.6: Middle cerebral artery Doppler. Taken from Baschat AA et al. Examination of the fetal cardiovascular system. Seminars in Fetal and Neonatal Medicine 2011; 16: 2-12.
35
Figure 1.7: Middle cerebral artery pulsatility index per gestation. Taken from Parra-Cordero M, Lees C, Missfelder-Lobos H, Seed P, Harris C. Fetal arterial and venous Doppler pulsatility index and time averaged velocity ranges. Prenat Diagn 2007; 27: 1251-7.
Cerebro-Placental ratio (CPR)
During fetal hypoxemia, there is an increase in the blood supply to the brain, myocardium
and the adrenal glands at the expense of reduced perfusion of the kidneys, gastrointestinal
tract and the lower extremities. This phenomenon called as ‘cerebral redistribution' or
‘brain sparing effect' was reported earlier in animal studies by Thornburg et al. in 1991.(61)
Wladimiroff et al. examined the cerebral and umbilical artery Doppler in normal and
growth-restricted fetuses and found that fetuses with growth restriction showed a raised Pi
in the umbilical artery and reduced index values in the internal carotid artery suggesting the
presence of ‘brain sparing effect'.(62)
Cerebroplacental ratio (CPR), which is the ratio of Pi in the MCA to that in the umbilical
artery, reflects both the placental status and the fetal response. The CPR was first reported
36
by Arbeille et al. that fetuses complicated by growth restriction or hypertension had a CPR <
1 compared to appropriately grown fetuses which had a CPR >1.(63) Several studies have
been published since then supporting the usefulness of CPR and it association in predicting
the risk of the adverse perinatal outcome in growth restricted fetuses.(64, 65) Longitudinal
reference ranges are available which show a gradual increase until 34 weeks and then
decline towards term (Figure 1.8).(66)
Bahado-Singh et al. analysed the fetal Doppler in 203 FGR fetuses and showed that lower
CPR was significantly associated with adverse perinatal outcomes associated with low birth
weight, meconium stained liquor, low APGAR scores, perinatal death and neonatal
admissions when compared with isolated umbilical artery Doppler changes.(67)
A multicentre prospective trial (PORTO study) by the Perinatal Ireland Research Consortium
looked at 1,100 consecutive singleton pregnancies over a two-year period. Adverse
perinatal outcome was defined by a composite score consisting of interventricular
enterocolitis, lung complications like bronchopulmonary dysplasia, neonatal sepsis and
death. The study showed that CPR less than 1 was associated with an 11-fold increase in the
risk of adverse outcome compared with normal CPR.(56)
37
Figure 1.8: Cerebroplacental ratio per gestation. Taken from Ebbing C, Rasmussen S, Kiserud T. Middle cerebral artery blood flow velocities and pulsatility index and the cerebroplacental pulsatility ratio: longitudinal reference ranges and terms for serial measurements. Ultrasound Obstet Gynecol 2007; 30: 287-96.
Some studies have shown that combining CPR with electronic fetal heart rate monitoring in
intrapartum surveillance reduces the risk of adverse intrapartum outcome and decreases
the risk of caesarean sections for fetal distress. Sirsistadis et al. in their prospective
controlled study looked at intrapartum outcomes in fetuses that were monitored by
electronic fetal heart rate monitoring alone and in combination with CPR. The results from
the study showed that fetuses with electronic fetal heart rate monitoring combined with
CPR had significantly lower rates of caesarean section for fetal distress and an improved
outcome with a lower risk of neonatal metabolic acidosis.(68)
Prior et al. performed a prospective observational study to predict intrapartum compromise
in AGA fetuses. He observed that fetuses delivered by caesarean section for fetal distress
38
had significantly lower CPR than those born by spontaneous delivery. Fetuses with CPR <10th
centile had a six-fold increased risk to be delivered by caesarean section while fetuses with
CPR >90th centile appeared protective of caesarean section for fetal distress.(69)
Ductus venosus
The venous vasculature in the fetus is primarily responsible in shunting significant amount
of oxygenated blood from the umbilical vein to the heart. The fetal liver along with the
venous vasculature consisting of the umbilical and portal veins, ductus venosus, hepatic vein
and the inferior vena cava play an import role in contributing to the pre-load to the heart.
The Ductus venosus (DV) is unique as it shunts a considerable amount of oxygenated blood
from the umbilical – portal system through the inferior vena cava to the right atrium. The
diameter of the DV is approximately 1/3rd of the umbilical vein. It courses posteriorly and
steeply in a cephalad direction as the original orientation of the umbilical vein and enters
the IVC in a venous vestibule below the diaphragm. The velocity of blood increases as it
passes through the DV due to its course and the narrow lumen.(70) It is estimated that in
normal fetuses, around 20-30% of the oxygenated blood bypasses the hepatic circulation
through the ductus venosus to reach to the right atrium.(26, 71) However, this could increase
up to 60% in fetal hypoxemia and growth restricted fetuses.(70)
The typical waveform in the Ductus venosus consists of a characteristic triphasic waveform
(Figure 1.9). The highest-pressure gradient occurring during ventricle systole between the
venous vessels and the right atrium is represented by the ‘S’ wave. Early diastole with
passive filling of the ventricles is associated with a second peak of forward flow which is
represented by the ‘D’ wave and the ‘a’ wave which represents atrial contraction, prevents
direct blood flow from the ductus venosus to the left atrium during this short period of
closure of foramen ovale. (72)
39
Figure 1.9: Ductus venosus waveform. Taken from Baschat AA. Examination of the fetal cardiovascular system. Seminars in Fetal and Neonatal Medicine 2011; 16: 2-12.
Many studies have shown abnormal ductus venosus flow in association with chromosomal
abnormalities, cardiac defects and adverse perinatal outcome.(73-75) Maiz et al. looked at the
combined data from eight studies and observed that abnormal DV blood flow was
associated with 87% of fetuses with cardiac defects, suggesting the use of DV as a secondary
marker in risk assessment of fetuses with raised nuchal translucency.(74, 76, 77)
Abnormal umbilical artery waveform evidenced by absent or reverse end-diastolic flow
represent an increased fetal-placental resistance. This is secondary to abnormal placental
villous vasculature resulting in poor nutritional transfer across the placenta in FGR fetuses.
Abnormal DV waveform account for a late vascular response in FGR fetuses resulting in
absent or reverse ‘a' wave. Further fetal compromise results in impaired cardiac pre-load
and afterload due to dysfunctional myocardium resulting in severe adverse perinatal
outcome including stillbirth.(72)
40
1.8 Fetal cardiac function
The importance of fetal echocardiography in diagnosing structural cardiac defects in utero is
well known. More recent research has allowed the prenatal cardiac function to be assessed
accurately.(78) Cardiovascular adaptations in utero secondary to placental insufficiency can
lead to altered fetal programming which persists in the form of subclinical cardiac and
vascular dysfunction and cardiac remodelling in neonates and children.(79) There is
substantial evidence that programming of adult cardiovascular disease begins prenatally
and fetal cardiac assessment can identify fetuses at risk of adverse perinatal outcome and
long-term cardiovascular dysfunction.(80)
Cardiac output and blood flow to the fetus in animal models suggest a right ventricular
dominance in the fetus compared to the postnatal life, and the reported ratio of right to left
cardiac output ranged from 1 to 1.5.(81) In the fetal lambs, the biventricular cardiac output in
the second half of pregnancy is approximately 450 mL/min/kg. Of this, about 60-65% of the
cardiac output is ejected by the right ventricle, and 35-40% is ejected by the left ventricle
thus giving a ratio of right to the left cardiac output of 1.5 o 1.85.(81) This cardiac ratio
changes postnatally with an increase in the left cardiac output to 240/mL/min/kg within the
first 2 hours and then stabilises to approximately 190 mL/min/kg. This decreases the left to
right shunt from 62 ml/min/kg to about 14 mL/min/kg.(81)
Studies in animal models have demonstrated changes in the fetal cardiac function in hypoxic
conditions and those with fetal growth restriction.(82) Chronic hypoxia induces adaptive
changes to the fetus in utero. These include erythropoiesis to increase oxygen transport,
angiogenesis in muscle to reduce oxygen diffusion distance, increase catecholamine release
and metabolic changes at a cellular level. Herrera et al. studied the cardiac effects of chronic
41
fetal hypoxia in rats that were independent of changes in nutrition in pregnancy. 30
pregnant rats in each group were housed under normoxic (21% oxygen) and hypoxic
conditions (13% oxygen) from Day 6 to Day 20 of the pregnancy. Pups that were housed
under hypoxic conditions showed a 176% increment in aortic wall thickness and a 170%
increment in the wall to lumen ratio of the fetal aorta when compared to the pups that
were kept under normoxic conditions.(83)(84) Pulgar et al. also observed that mild chronic
hypoxia induced by repeated cord occlusion in sheep showed a detrimental effect on fetal
cardiovascular and neurological outcomes.(85)
Tchirikov et al. measured the cardiac output and blood flow redistribution in fetal sheep
models subjected to hypoxia. He observed a significant reduction the values of p02, fetal pH
and base excess in hypoxic fetuses and a significant increase in the proportion of blood
passing through the ductus venosus in hypoxic fetuses resulting in the reduction in the
placental fraction of cardiac output and the right to left heart ratio.(86) Kiserud et al.
subsequently observed similar results when measuring the cardiac output in fetuses with
intrauterine growth restriction. They found that although the overall cardiac output was
maintained, the placental fraction of blood flow was lower due to increased fetal demands
resulting in increased recirculation of fetal blood flow.(87)
Following animal experiments, there have been studies on the application of conventional
and modern ultrasound techniques to measure fetal cardiac function with longitudinal
reference ranges in fetuses across the gestation. Mielke et al. performed a cross-sectional
study using 2D and Doppler echocardiography in 222 normal singleton fetuses from 13 to 41
week’s gestation (Figure 1.10 and 1.11).(81) The median biventricular cardiac output was
estimated to be 425 mL/min/kg with a clear right heart dominance evidenced by the right
cardiac output contributing to 59% to the total cardiac output. They had also observed that
42
the pulmonary flow to cardiac output was higher when compared to the lamb models. The
average normal cardiac output between 18-41 weeks gestation was about 425 /mL/min/kg
with one-third of the fetal combined cardiac output (CCO) being distributed to the placenta
in most of the second half of the pregnancy.(81)
The most significant change in the precordial veins when cardiac dysfunction occurs is
reflected as reversal or absence of ‘a' wave in the DV. It has been shown that reversed or
absent ‘a' wave is associated with a 63% risk of fetal and neonatal death.(88) Makikallio et al.
have shown that fetuses with elevated levels of markers of myocardial dysfunction
(Troponin or N –Terminal pro –atrial natriuretic peptide) also had abnormal Pulsatility index
of the ductus venosus and the IVC.(89)
Figure 1.10: Right cardiac output across gestation. Taken from G Mielke et al. Cardiac output and central distribution of blood flow in the human fetus. Circulation 2001; 103: 1662-1668.
43
Figure 1.11: Left cardiac output across gestation. Taken from G Mielke et al. Cardiac output and central distribution of blood flow in the human fetus. Circulation 2001; 103: 1662-1668.
Although early onset FGR confers a significant risk of perinatal mortality and morbidity,
constitutionally small fetuses have been considered to have a good prognosis.(90) However,
recent evidence suggests that a proportion of these fetuses that represent late onset fetal
growth restriction beyond 32 weeks also have a mild degree of placental insufficiency that is
not reflected on routine umbilical artery Doppler screening. These babies are at risk of
adverse neurodevelopment and cardiovascular disease in adult life.(91-93)
It is also shown that around 30% of late-onset SGA fetuses with normal umbilical artery
Doppler have increased myocardial perfusion indices suggesting that compromised cardiac
function.(94, 95)
44
M-Mode Echocardiography is the study of the two-dimensional motion of all structures
along the line of the ultrasound beam. This technique is primarily used to record both atrial
and ventricular activity to check for conduction and diagnose atrioventricular block. At late
gestation, shadows from adjacent structures and the ribs result in acoustic shadowing
leading to poor heart tracing and inconsistencies in obtaining the measurements. For these
reasons, we decided not to include the M-Mode assessment in the study of fetal cardiac
function in our studies.
Fetal echocardiographic assessment is routinely performed using 2D ultrasound with
Doppler. New techniques for assessment of fetal cardiac function, including the
spatiotemporal image correlation (STIC), tissue Doppler imaging and speckle tracking may
not be suitable for routine clinical application due to the complexity of the techniques and
the skill required to learn and reproduce with minimal inter and intra-observer variability. In
addition, the reproducibility of using 2D Doppler was better compared to using STIC. (78,96)
The table below illustrates the standard cardiac functional assessments performed by fetal
echocardiography in clinical practice (Table 1.2). For simplicity and if this would make a
difference to the clinical practice, we decided to use the standard 2D fetal echo assessment
Systolic annular peak velocity Speed of movement of AV valve in systole Spectral or Colour TDI
Myocardial strain and strain rate Amount and speed of deformation of myocardial segment
Colour TDI or2D speckle tracking
Diastolic Function
Precordial vein blood flow patterns Pattern of blood flow during atrial contraction
Conventional Doppler
E/A Ratio Ratio between early and late ventricular filling velocity
Conventional Doppler
Diastolic annular peak velocity Speed of movement of AV valve at the beginning of and late Diastole
Spectral or Colour TDI
Isovolumetric relaxation time (IRT) Conventional or Spectral Doppler/ Colour TDI
Global Cardiac function
Myocardial performance index ICT + IRT / ET Conventional Doppler or spectral / Colour TDI
STIC – Spatiotemporal image correlation, TDI – Tissue Doppler imaging, IRT – Isovolumetric relaxation time, ICT – Isovolumetric contraction time, MPI – Myocardial performance index, SV – stroke volume, EDV –End diastolic volume, ET – Ejection time
Table 1.2: Cardiac function parameters. Taken from Crispi F et al. Fetal cardiac function: Technical considerations and potential research and clinical applications. Fetal diagnosis and Therapy 2012; 32: 47-64.
46
1.9 Summary
Global hypoxic-ischemic injury to the brain remains a significant cause of mortality and
severe morbidity. Significant improvements in antenatal care management and intrapartum
fetal monitoring has not shown to significantly reduce adverse perinatal outcome for the
last 50 years. Many studies have shown that the current methods of intrapartum monitoring
lack specificity with a high rate of inter-observer variability. These observations could result
in inaccuracies in the diagnosis of intrapartum fetal distress leading to an increased rate of
emergency caesarean sections. Systematic reviews using the combination of various
intrapartum assessment techniques to electronic fetal heart rate monitoring has failed to
show a reduction in caesarean section for fetal distress.
Numerous publications in the past have indicated that addition of intrapartum ultrasound
with fetal Doppler in combination with electronic fetal heart rate monitoring have proved to
improve detection of fetuses that tolerate poorly in-utero. Prior et al. from our research
group has shown that low CPR less than the 10th centile in AGA foetuses at term is
significantly associated with adverse intrapartum outcome.(69)
Studies have also been published on the assessment of cardiac function in fetuses at risk of
compromise due to maternal or fetal causes. However, there had not been any previously
published research in the evaluation of cardiac function of AGA fetuses at term. This is the
first study that has considered measuring the fetal cardiac function before labour in AGA
fetuses and comparing with the obstetric and neonatal outcome.
47
Chapter 2 Methods
2.1 Introduction
Previously published studies have measured the fetal cardiac function in normal and hypoxic
fetuses across the gestation; however, this is the first study that has measured fetal cardiac
output in appropriately grown term singleton fetuses in nulliparous women before labour. It
is also known from previously published studies that there is a change in the fetal cardiac
output in fetuses with chronic hypoxemia and growth restriction in utero; however, there
has not been reported studies that considered the feasibility to conduct assessment of
cardiac output in AGA fetuses at term to identify fetuses at risk of adverse obstetric and
neonatal outcome.
2.2 Aim
To measure fetal cardiac output and fetal Doppler (Cerebroplacental ratio) in singleton AGA
fetuses at term in nulliparous women before labour.
2.3 Hypothesis
Fetuses that require emergency caesarean section for intrapartum fetal distress will have
poor cardiac function and low CPR than fetuses who do not. Reliable identification of
fetuses at risk of adverse intrapartum events will assist in the management of these fetuses
during labour.
48
2.4 Methods
This prospective observational study was conducted at Queen Charlotte's and Chelsea
Hospital, London U.K between March 2013 and February 2015. Leaflets describing the study
were provided to pregnant women attending their routine antenatal clinic and midwifery
appointments. Study leaflets were also displayed at the antenatal clinic, antenatal ward,
delivery suite and in the day assessment unit to facilitate recruitment.
Pregnant women who agreed to participate in this study and met the inclusion criteria were
given a copy of the study information sheet (Appendix A). They were given sufficient time to
read the information and to discuss the study with the researcher. Participants who agreed
to the study were then asked to sign the consent form to be included in the research
(Appendix B).
The inclusion criteria were nulliparous women with AGA term singleton fetuses (37-42
weeks inclusive gestation) who were either in early labour or had induction of labour.
Exclusion criteria included cervical dilatation more than 4 cm, pre-eclampsia, maternal
diseases like diabetes, hypertension, diagnosis of fetal growth restriction, fetal anomaly,
chromosomal or genetic abnormality, evidence of congenital fetal infections or maternal
age less than 16 years. All women recruited to the study were delivered within 72 hours.
Ethical approval for this study was granted by the London Research Ethics Committee (Ref
no: REC 10/H0718/26).
Ultrasound examination of the fetal biometry and fetal weight estimation was performed by
calculation of the bi-parietal diameter, head circumference, abdominal circumference and
the femur length. The amniotic fluid volume and the deepest pool of liquor were also
measured as part of the study. Estimated fetal weight was then calculated using the Hadlock
49
formula.(97) Fetal Doppler indices of the umbilical artery and middle cerebral artery were
measured, and the cerebro-placental ratio (CPR) was calculated by dividing the middle
cerebral artery pulsatility index by the umbilical artery pulsatility index.
The fetal cardiac function was measured by conventional 2D and Doppler ultrasound. We
performed the assessment of the systolic and diastolic function of the ventricles and the
flow velocity across the inflow and the outflow tracts of the heart. The results obtained
were then used to calculate the stroke volume, cardiac output and the myocardial perfusion
index.
2.5 Ultrasound assessment
Fetal biometry
The 2D fetal ultrasound and Doppler examination was performed with GE Voluson-E8
ultrasound machine with 4-8 MHz probe (GE Medical Systems, Zipf, Austria and
Buckinghamshire, HP8 4SP, U.K)
Fetal biometry was performed according to guidelines published by the international society
of obstetrics and gynaecology.(98, 99) The fetal presentation was confirmed by ultrasound
examination to ensure that fetuses with cephalic presentation were included in the study
population. Pregnant mother was positioned in a semi supine position rather than left
lateral decubitus position. The head rest was elevated to an angle of 45 degrees to prevent
aorto-caval compression. Studies have shown that this position is associated with minimal
changes in the cardiac output when compared to the lying position.(100)
50
The biparietal diameter and the head circumference were measured after obtaining an axial
sectional plane of the fetal head in the trans-thalamic plane with the falx in the midline. The
biparietal diameter was then calculated by placement of the calliper from the outer table to
the inner table of the fetal calvarium. For the head circumference, elliptical trace method
was used to determine the outer perimeter of the calvarium excluding the soft tissue of the
scalp.
The fetal abdominal circumference was measured by elliptical trace method at the level of
the skin line after obtaining a transverse section of the fetal abdomen at the level of the
junction of the umbilical vein with portal sinus and fetal stomach in the field of view. Femur
length was measured after obtaining a long axis of the bone with the angle of insonation
perpendicular to the shaft of the bone. The callipers were placed along the long axis of the
bone between the metaphysis excluding the femoral epiphysis and the cartilage.
Amniotic fluid volume index and the single deepest pool of liquor was calculated by dividing
the maternal abdomen into four quadrants by an imaginary line drawn across the umbilicus
and another perpendicular from the symphysis pubis below to the xiphoid process above.
Longitudinal measurement of the maximum vertical pool of amniotic fluid was identified
and measured avoiding fetal parts or the umbilical cord in the field of view.
Doppler ultrasound
Doppler indices of the Umbilical artery and middle cerebral artery of the fetus were
obtained before assessment of the fetal cardiac function. The fetal Doppler assessment was
performed according to the standardised published guidelines (27) regarding the technique
and waveform analysis using appropriate pulse repetition frequency and wall motion filter
51
for the vessel under examination. The angle of insonation was kept close to zero degrees at
all times if possible for Doppler evaluation; however, in the assessment of the middle
cerebral artery Doppler, the angle correction was kept to zero degrees at all times.(27) High
pass filter was activated in the machine to limit the noise from vessel wall movement. At
least 5 consecutive waveforms were obtained in a single examination which was repeated
three times for assessment of each vessel. Indices were calculated using automated
software installed in the equipment to prevent errors by manual tracing method and the
mean value was used for data analysis.
Umbilical artery Doppler assessment was performed in the free loop since most of the
published literature with the reference ranges are obtained by free loop examination.(101, 102)
There is a variation in the flow velocity with higher values are seen closer to the fetal cord
insertion. However, it was difficult to assess the Doppler flow close to the fetal cord
insertion at later gestation due to the poor acoustic window and limited views due to the
fetal position.
Middle cerebral artery Doppler was performed after obtaining an axial section of the fetal
brain to visualise the sphenoid wings and the thalami. Colour Doppler is then used to
identify the circle of Willis, and the middle cerebral artery was sampled at the proximal third
according to the criteria in published guidelines.(27)Minimal pressure was obtained while
obtaining the measurements of the MCA Doppler to avoid excessive compression to the
fetal head while obtaining the readings.
52
2.6 Fetal cardiac function
The following systolic and diastolic cardiac functional parameters were measured for
our study.
Diastolic function
a) E/A ratio
Systolic Function
a) Assessment of outflow tracts
b) Stroke volume (SV), Right, left and combined cardiac output
Left ventricular myocardial performance index – assessment of global cardiac function
2.7 Diastolic function
E/A Ratio
The E/A ratio is performed with spectral Doppler through the atrioventricular valves with
the heart either in a posterior or an anterior apical projection (Figure 2.1). The
interventricular septum is aligned at zero degrees with the Doppler beam before obtaining
the measurement, and the angle of insonation is kept below 20 degrees to get the
waveform. The Doppler gate is placed just below the A-V valves and set to 2-3 mm to avoid
contamination with artefacts resulting from wall motion and outflow tracts. The pulse
repetition frequency (PRF) is adjusted so that the waveform occupies at least 75% of the
scale. Three to five symmetrical waveforms were obtained, and the average measurement
was taken for analysis.(103)
The first component of the waveform is the ‘E’ wave related to the process of myocardial
relaxation followed by the second wave (A wave) that represents atrial contraction during
53
ventricular filling. The E/A ratio is obtained by dividing the peak velocities of E over A
waveform as shown below.(103)
Figure 2.1: 2D Fetal cardiac Doppler – Diastolic function. Taken from Hernandez-Andrade E et al. Evaluation of
conventional Doppler fetal cardiac function parameters: E/A ratios, outflow tracts, and myocardial
performance index. Fetal diagnosis and therapy. 2012;32(1-2):22-29.
Ductus venosus flow pattern
Analysis of the venous flow channels contiguous with the right atrium provides a good
approximation of the pressure gradients within the right atrium thus indirectly reflecting
cardiac compliance. An attempt was made to study the waveform from the ductus
venosus(DV) as described in the methods; however, it was not possible to get a consistent
waveform of the DV in our study population. This was due to multiple factors like fetal
position, acoustic shadowing from the spine and ribs, fetal diaphragmatic movements, the
narrow lumen of the vessel diameter at late gestation and a close approximation of the
hepatic veins with the DV that resulted in sampling error and inconsistent waveform for
analysis. Therefore, we were didn’t include the analysis of the Ductus venosus in our study.
54
2.8 Systolic function
Assessment of outflow tracts, Right, left and combined cardiac output
Systolic function of the heart is measured by recording the velocity of blood ejected by the
ventricles, which would allow estimation of stroke volume and the cardiac output (Figure
2.2). Differential cardiac output assessment provides valuable information regarding blood
flow to different regions in the fetus. Measurements of aortic flow reflect changes in the left
ventricle and pulmonary arterial flow reflect that of the right ventricle.(104)
The aortic outflow tract is evaluated on a long axis of the left ventricle. This view is obtained
from an apical 4-chamber view with the transducer turned slightly towards the right
shoulder of the fetus. This technique exposes the aorta as a single vessel in continuity with
the interventricular septum. The pulmonary artery is evaluated either in a short or long axis
view of the right ventricle. The short axis is obtained from the 4-chamber view by rotating
the transducer to the fetal left side; the long axis is achieved by slightly displacing the
transducer from the four chambers towards the fetal head. The angle of insonation is kept
close to zero as possible during Doppler acquisition to obtain the best readings.(103)
The peak systolic velocity, velocity time integral and ejection time is obtained as shown in
the shown in the figure below to calculate the stroke volume, ejection fraction and the
cardiac output.(103)
55
Figure 2.2: 2D Fetal cardiac Doppler-Systolic function. Taken from Hernandez-Andrade E et al. Evaluation of
conventional Doppler fetal cardiac function parameters: E/A ratios, outflow tracts, and myocardial
performance index. Fetal diagnosis and therapy. 2012;32(1-2):22-29.
For assessment of the cardiac output, it is important to measure the valve area and the
velocity time integral of the aortic and the pulmonary valve respectively to obtain the stroke
volume which then multiplied by the heart rate to obtain the cardiac output.
The valve area is calculated by using the formula πr2 or (3.14 x valve diameter/2)2. The
velocity time integral for the aortic and pulmonary valve is calculated by manually tracing
the Doppler signal on the corresponding waveform that provides the ejection velocity,
ejection time, heart rate and the velocity time integral of the corresponding valve. Stroke
volume of the left and the right ventricle is calculated by multiplying the velocity time
integral by the valve area of the aortic and the pulmonary valve respectively. Cardiac output
of the respective ventricles is obtained by multiplying the stroke volume and the heart rate.
56
The weight adjusted cardiac output (mL/min/kg) of the right and left side is calculated by
dividing the corresponding cardiac output by the estimated fetal weight and the combined
cardiac output is the sum of both ventricular outputs.
2.9 Left Ventricular Myocardial Performance Index (LV - MPI)
The left ventricular myocardial performance index is obtained with a cross-sectional view of
the fetal thorax in the apical projection showing a good 4-chamber view (Figure 2.3). The
Doppler gate is then placed to include both the lateral wall of the ascending aorta, and the
mitral valve where the clicks correspond to the opening and closing of the valves are clearly
seen. The sample volume should be 2-4 mm, and the gain is optimised so that the valve
clicks are visualised and appear more echogenic than the E/A wave and aortic
waveforms.(103)
The E/A waveform and the aortic waveform should remain visible always during the process,
and the sweep velocity is set to maximum. The E/A waveform is displayed as a positive flow.
Isovolumetric contraction time (ICT), Isovolumetric relaxation time (IRT) and Ejection time
(ET) are calculated as described in the figure below. The cursor is placed just before the
echo of each valve click with care to avoid overlapping with the echogenic reflection from
the valve.(103) The myocardial performance index is obtained by the adding the isovolumetric
contraction(ICT) and relaxation(IRT) time divided by the ejection time(ET) of the left
ventricle
(LV.MPI = ICT + IRT / ET). Each cardiac parameter was recorded three times, and a mean of
the values was used for analysis.
57
Figure 2.3: 2D Fetal cardiac Doppler -MPI. Taken from Hernandez-Andrade E et al. Evaluation of conventional
Doppler fetal cardiac function parameters: E/A ratios, outflow tracts, and myocardial performance index. Fetal
diagnosis and therapy. 2012;32(1-2):22-29.
The right ventricular MPI can also be obtained in a similar way as the left ventricle by
analysis of the waveforms at the tricuspid and pulmonary artery valves; however due to
their different anatomical configuration; they cannot be captured simultaneously for
waveform analysis. Due to the above limitations, assessment of right ventricular MPI is less
frequently used in clinical practice; therefore, we did not perform the assessment of right
ventricular MPI in our methodology.(105)
All data generated from this study were initially entered to a storage database (Microsoft
Excel – 2013) and subsequently transferred to statistical analysis software (Graph Pad Prism
version 6.03, Graph Pad Software Inc, La Jolla, CA 92037 United States of America) for
further analysis.
58
Chapter 3 – Pilot study
3.1 Introduction
There have not been previously published studies measuring the fetal cardiac output in
appropriate for gestational age fetuses at term prior to labour. We therefore could not
obtain data required for power calculation for our study. It was also intended to evaluate if
this study was feasible to be performed prior to active labour.
Prior et al.(69)from our unit had published his data on the assessment of intrapartum hypoxia
by measurement of the cerebroplacental ratio before labour by performing a similar pilot
study since there had not been previously published reports to generate a sample size. We
therefore decided to recruit similar numbers based on the lack of evidence to obtain the
data for analysis and perform a power calculation for a larger study.
3.2 Aims
1 To measure fetal cardiac function and fetal Doppler (cerebroplacental ratio) in
appropriate for gestational age singleton fetuses at term before labour in nulliparous
women.
2 To generate the mean and standard deviation for cardiac functional parameters
from the data to perform power calculation and calculate a sample size to achieve a
statistical power of >0.80.
59
3.3 Materials and Methods
135 patients were recruited to this prospective observational pilot study at Queen
Charlotte's and Chelsea Hospital, London U. K for nine months from March 2013 until
November 2013. Leaflets describing the study were provided to pregnant women attending
their routine antenatal clinic and midwifery appointments. Study leaflets were also
displayed at the antenatal clinic, antenatal ward, delivery suite and in the day assessment
unit to facilitate recruitment.
Pregnant women who agreed to participate in this study and met the inclusion criteria were
given a copy of the study information sheet (Appendix A). They were given sufficient time to
read the information and to discuss the study with the researcher. Participants agreed to
the study were then asked to sign the consent form to be included in the research
(Appendix B).
The inclusion criteria were nulliparous women with appropriately grown normal term
singleton fetuses (37-42 weeks inclusive gestation) who were either in early labour or had
induction of labour. Exclusion criteria included cervical dilatation more than 4 cm, pre-
eclampsia, maternal diseases like diabetes, hypertension, diagnosis of fetal growth
restriction, fetal anomaly, chromosomal or genetic abnormality, evidence of congenital fetal
infections or maternal age less than 16 years. All women recruited to the study were
delivered within 72 hours. Ethical approval for this study was granted by the London
Research Ethics Committee (Ref no: REC 10/H0718/26).
60
3.4 Results
The patient’s demographic information (Table 3.1) were recorded in the Appendix C before
starting the examination.
The entire ultrasound assessment was completed in about 30 to 45 minutes depending on
the fetal position and the availability of adequate views for assessment. Data obtained from
this study was not made available to the clinicians responsible for the patient’s intrapartum
care and labour was managed as per local protocols and guidelines. All data were initially
stored on the ultrasound machine’s hard drive and subsequently downloaded to an external
hard drive for off-line analysis.
Intrapartum and neonatal outcome were collected from the patients and baby case medical
records. Intrapartum evaluation included details of electronic fetal heart rate monitoring,
and isolated electronic fetal heart rate monitoring analysis showed no difference in the
overall caesarean section rates (22)
Visser et al. in 2015 published the FIGO consensus guidelines on intrapartum fetal
monitoring. The study group looked at the combination of adjunctive technologies in
addition to electronic fetal heart rate monitoring to assess fetal oxygenation to reduce the
false positive cases resulting in unnecessary fetal interventions. The study concluded that
there was still much uncertainty regarding the use of different adjunctive technologies in
intrapartum fetal monitoring. The guidelines also suggest that in order to improve the
intrapartum fetal monitoring is to learn and understand the pathophysiology of the fetal
response following reduced oxygenation during labour.(150)
164
Studies that have included fetal Doppler in addition to electronic fetal heart rate monitoring
have shown to be more predictive of adverse intrapartum outcome rather than using
electronic fetal heart rate monitoring in isolation.(129) Our study has shown that assessment
of fetal cardiac function in AGA fetuses at term in addition to the fetal Doppler could
identify fetuses at risk of intrapartum fetal distress.
Fetal echocardiographic assessment is routinely performed using 2D echo with Doppler.
There have been significant improvements in the assessment of fetal cardiac function by
modern techniques alongside M mode, conventional 2D echo and Doppler ultrasound. The
newer modern cardiac assessment techniques are not practically suitable for day to day
clinical application due to the complexity of the techniques and the skill required to learn
and reproduce with minimal inter and intra-observer variability.(96)
Previous publications have shown that although 3D and 4D ultrasound techniques are
reliable than standard 2D and Doppler assessment for calculating the stroke volume and
cardiac output(151-153); However, there are many disadvantages in the implementation of this
method as a choice for screening due to the following reasons.
The newer 3D and 4D imaging methods involve complex post processing technology that is
not available with standard ultrasound equipment in day to day clinical practice. It may also
require a longer period of learning as every clinician or sonographer is not competent in
performing 3D ultrasound in routine clinical practice. 3D ultrasound can also be technically
challenging at late gestation due to fetal breathing movements which may compromise
image quality. Finally, it is important to note that the clinical expertise to post process and
review images from these new imaging modalities is not available in every clinical setting.
165
While 2D fetal echo and Doppler evaluation require additional skills and training, integrating
these additional examinations should be relatively easy to the existing clinical practice since
most of the doctors and sonographers are familiar with routine assessment of the fetal
heart as part of the fetal anomaly screening programme. Given the technical limitations and
complexity of the assessment of cardiac function by the newer imaging methods, it is
probably wiser to use the simplest and most validated techniques and gain experience with
these techniques for clinical assessment and can be implemented on a large scale screening
if found to be effective.(154)The whole examination was completed in 30-45 minutes which
would roughly be the time required to perform a routine obstetric scan suggesting the
convenience of using this technique in a regular clinical setting
All the scans in our study were conducted by an experienced single operator, and each
measurement was taken three times with the average of the measurements used in analysis.
The technique and measurements were performed per the standard published guidelines
thereby eliminating examination bias.
Analysis of the venous flow channels contiguous with the right atrium provide a good
approximation of the pressure gradients within the right atrium thus indirectly reflecting
cardiac compliance. An attempt was made to study the waveform from the Ductus
venosus(DV) as described in the methods earlier. However, it was not possible to consistent
wave form for analysis in all our population in the pilot study. This was due to multiple
factors like fetal position, acoustic shadowing from the spine and ribs obstructing the view
of the ductus on axial and sagittal planes, fetal diaphragmatic movements resulting in poor
sampling in addition to the narrow lumen of the vessel diameter at late gestation. The
hepatic veins near the ductus venosus also led to inadequate sampling leading resulting in
166
an incorrect waveform for analysis. Hence for the above reasons we could not include the
Ductus venosus analysis in our study.
Induction of labour constituted 79% of our recruited population, and the remaining 21% of
the women recruited were in spontaneous or early labour. Despite information of the study
available to patients, most of the women interested in participating in the study had either
progressed into active labour before recruitment and hence could not be enrolled into our
study. This study was performed by a single operator, and it was not possible to recruit the
patients, who arrived in early labour to triage during different times of the day and night.
Observational studies have supported the argument that induction of labour increases the
rate of caesarean sections, whereas reviews of post-date pregnancies and term prelabour
rupture of membranes suggest either no difference or reduction in the risk of caesarean
section. Wood et al.(112)performed a systematic review and meta-analysis of trials in women
with intact membranes. They reviewed 37 RCT’s of which 27 were trials of uncomplicated
pregnancies at 37-42 week’s gestation. The authors concluded that a policy of induction was
associated with a reduction in the risk of caesarean section compared with expectant
management (O.R =0.83, 95th CI 0.76 to 0.92).
A critical aspect of any new intervention or investigation is the acceptability of the
technique to patients. However, we observed very high rate of patient acceptance for
ultrasound examination before labour. Patients find an additional ultrasound examination
before delivery as an enjoyable and reassuring experience because additional scans are
currently not offered to low-risk pregnant women on the NHS antenatal screening
programme. The few patients who declined to participate in the study prior to enrolment
167
have cited reasons as being uncomfortable due to pain from active contractions or
unwillingness to undergo examination by a male doctor for religious/ethical reasons. These
issues are unlikely to persist if multiple operators can be trained to perform the study to
translate the evidence from research towards clinical practice.
7.2 Conclusions
This study was aimed to measure the fetal cardiac output before the onset of active labour
and to correlate with obstetric and neonatal outcome. This study is also the first study to
measure fetal cardiac function in AGA term fetuses before active labour in nulliparous
women.
Positive predictive parameters Relative risk Positive LR
CPR <10th centile 2.7 3.25
LCO/ml/min/kg <10th centile 2.7 3.25
Ratio of RCO to LCO >90th centile 4.3 5.97
Table 7.01: Relative risk and likelihood ratios in prediction of CS for fetal distress
Results from the Doppler study of cerebro placental ratio showed that fetuses delivered by
emergency caesarean section for fetal distress had a significantly low CPR compared to the
rest of the fetuses(p<0.0001). Fetuses with CPR less than 10th centile were 2.7 times more
likely to be delivered by caesarean section for fetal distress when compared to the rest of
the fetuses (Table 7.01). Fetuses with CPR >90th centile was protective for fetal distress
(NPV-100%).
168
The results of our study have shown that pre-labour assessment of cardiac function in
appropriately grown term singleton fetuses can identify fetuses at risk of subsequent
intrapartum fetal distress.
In fetuses that develop intrapartum fetal distress in utero, we observed a difference in the
prelabour cardiac function.
There was no difference in the diastolic function of the heart in these fetuses; however
significant differences were observed in the systolic function. The left cardiac output and
the difference between the right and left cardiac output were significantly different when
fetuses were grouped per the indication and mode of delivery. Fetuses with left cardiac
output < 10th centile were 2.7 times more likely to be delivered by caesarean section for
fetal distress when compared to the rest of the fetuses. However, fetuses with LCO >90th
centile appeared to be protective for caesarean section for fetal distress (NPV-100%).
Significant difference in the ratio of the right to the left cardiac output was also observed in
fetuses that were delivered by emergency caesarean section for fetal distress.
While there was no change in the overall cardiac output, fetuses delivered by caesarean
section for fetal distress had the highest ratio difference between the right and the left
cardiac output when compared with rest of the fetuses(p=0.0019). Fetuses with highest
ratio difference >90th centile were 4.3 times more likely to be delivered by emergency
caesarean section for fetal distress when compared with rest of the fetuses in our study
population.
169
The ratio of the right to the left cardiac output was also found to be superior in the
prediction of intrapartum distress when compared to the left cardiac output and the
cerebro placental ratio.
The detection rate in the prediction of fetal distress for a 10% false positive rate using the
ratio of the RCO to LCO >90th centile was 41%. This was higher when compared to the LCO
less than 10th centile (29 %) which was higher than the CPR with a detection rate of 27%.
The positive predictive value in prediction of intrapartum fetal distress by using the ratio of
RCO to LCO was 45%. This was higher when compared to the LCO<10th centile that had a
detection rate of 37% and by comparison was found to be superior to the CPR <10th centile
with a detection rate of 35%.
Results from the binary logistic regression that adjusts for the influence of the potentially
confounding variables showed the LCO and the ratio of the RCO to LCO remained significant
even when the CPR was included in the model suggesting that they are independent
predictors for caesarean section for fetal distress. For the same reason, there was not a
strong linear correlation between the CPR and the LCO and between the CPR and the ratio
of the right to the left cardiac output.
7.3 Potential clinical application and further research
Despite significant advances in intrapartum fetal monitoring, there has not been a
significant decrease in the overall rate of caesarean sections for the past three decades. One
in 4 babies (25%) is currently delivered by caesarean section making it the most commonly
170
performed operation in the world. There is a wide variation in the caesarean section rates
across the countries and continents around the world with numbers as little as 2% to as high
as 50%. (155, 156) Luz Gibbons et al. in their world health report published in the year 2010
obtained data from 137 countries performing caesarean sections. The results from the data
showed that 54 countries had caesarean section rates below 10%, whereas 69 countries had
shown rates above 15%. Around 10%(14) of the countries had caesarean rates between 10
to 15%.(157)The cost of global excess due to these procedures was estimated approximately
2.32 billion U.S Dollars, while the expense of the global need for caesarean section
approximated a modest amount of 432 million U.S Dollars.
There is an inverse relation between the caesarean section rates and the maternal and
infant mortality rates. However, the caesarean section above a certain limit have not shown
to provide additional benefit while some studies have shown that higher caesarean section
rates could be linked to negative consequences in maternal and child health.(157) Molina et al.
in 2015 published her results after examining the relationship between population level
caesarean delivery rates compared with maternal and neonatal mortality in 194 WHO
member states. The results showed that national caesarean delivery rates of up to
approximately 19 per 100 live births were associated with a lower maternal or neonatal
mortality among the member states.(158)
Caesarean section is being considered as one of the safety operative procedures although
it's not without the risk of surgical complications and adverse outcome. Liu et al. compared
spontaneous vaginal delivery with elective caesarean sections and found that caesarean
section had three times higher risk of severe maternal morbidity compared to spontaneous
vaginal delivery. This included major complicates like cardiac arrest, venous
171
thromboembolism, haemorrhage resulting in hysterectomy or infection. There was also an
increased rate of respiratory distress syndrome in fetuses that were delivered by caesarean
section compared to vaginal delivery.(159)
The observations in our study regarding fetal hemodynamics in AGA fetuses at term provide
information regarding the sub optimal placental function may enable better monitoring of
these fetuses. Despite significant advances in the obstetric care, it is not possible to
significantly reduce the overall rate of stillbirth. A global study by Lawn et al. showed an
estimated 2.6million third trimester stillbirth occurred in 2015. Although the etiology is
multifactorial with no obvious cause identified in majority of the cases, most of them are
linked to placental complications, either with fetal growth restriction or preterm labour or
both. They also observed in their study that prolonged pregnancies contribute to 14% of the
still birth rates.(160)
From the recent data published by the office of the national statistics -U. K, there were
695,233 live births in England and Wales in 2015. 161 The stillbirth rate was 4.5 per 1000
total births with no significant change compared to previous years. The rate of still birth is
still high in the U.K when compared with other wealthy developed countries around the
world.(161) United Kingdom is ranked 21 out of 35 of the world's richest countries and is
currently ranked behind Croatia, Poland and the Czech Republic in still birth rates. The
United Kingdom's reduction in the annual rate of reduction of stillbirth is at 1.4% which
places the country at the 114th place in the global list for the progress made on the decrease
in still birth.(160)The report from MBRRACE -UK (Mothers and babies: reducing risk through
audits and confidential enquiries across the U.K) have observed a big variation in stillbirth
across the U.K by region with the highest rate of still births observed in Yorkshire, Humber,
172
West Midlands and Wales (5 to 5.2%). Similarly, a higher rate of still birth was observed with
women of poorer backgrounds and when classified by ethnicity with Asian and African/Afro-
Caribbean mothers at greater risk when compared to the Caucasian population.
The National Health Service (NHS) in the U.K is currently able to offer two scans for pregnant
women. The first scan is offered between 11 to 14 weeks as part of dating the pregnancy
and combined screening test risk assessment for common trisomies. The second scan is
offered between 18-23 weeks for fetal anomaly evaluation in the context of the Fetal
antenatal screening programme. There are no additional scans offered for pregnant women
for rest of the pregnancy unless there are clinical indications or previous obstetric history of
adverse outcome. However, some NHS trusts in the U.K are able to provide additional third
trimester scans to pregnant women.
There have been many publications with conflicting observations regarding additional scans
in the third trimester. The latest Cochrane database of Systematic reviews by Bricker et al. in
2015(162) concluded that there was no difference in the primary outcomes of perinatal
mortality, preterm birth less than 37 weeks, caesarean section rates and induction of labour
rates if ultrasound in late pregnancy was performed routinely or not. However, the data was
lacking for the other primary outcomes that included preterm birth less than 34 weeks,
maternal psychological effects and neurodevelopment at the age of two. However, the POP
study in 2015 published in the LANCET showed that screening of nulliparous women with
universal third-trimester scan roughly tripled the detection of SGA infants that were at
increased risk of neonatal morbidity.(163) Similarly, another study by Roma et.al compared
the use of routine third-trimester ultrasound at 32 and 36 weeks in predicting the outcome.
They observed that there were no significant differences in the perinatal outcome between
173
the scans performed at different gestations; however, the detection rate for fetal growth
restriction was superior at 36 weeks scan when compared with 32 weeks scan.(164)
suggesting that sub optimal placental function at advancing gestation can result in adverse
intrapartum outcome in a small cohort of AGA fetuses at term. It is currently not possible to
identify this group of fetuses at risk of adverse intrapartum outcome.
Fetal growth restriction as discussed before is a significant risk factor for adverse outcome
including the risk of stillbirth. However, approximately two-thirds of the still born fetuses at
term have a birth weight greater than the 10th centile. Hence it is important to understand
that most the fetuses at risk of adverse intrapartum outcome at term are not small, but are
appropriate for gestational age. Sub-optimal placental function rather than abnormal
placenta at late gestation may contribute to the adverse outcome in these fetuses.
Many studies have been published regarding the usefulness of CPR in predicting the risk of
adverse outcome. Khalil et al. showed that the combination of estimated fetal weight, CPR
and uterine Doppler in the third trimester could identify the majority of fetuses at risk of
stillbirth.(64) Similarly, Akolekar et al. looked at the performance of screening for all stillbirth
due to impaired placentation, unexplained or other causes by a combination of maternal
factors, fetal biometry and uterine artery pulsatility index and then compared with the
screening by the uterine artery Pi alone. His research involved 70,003 singleton pregnancies
and observed that combined screening predicted 55% of all stillbirths, including 75% of
cases due to impaired placentation and 23% due to other causes for a false positive rate of
10%. The detection rate was higher by the combined screening approach rather than using
uterine artery Pi in isolation.(165)
174
Induction of labour is currently offered in our unit beyond 41 weeks in most of the
uncomplicated postdate pregnancies. Apart from presentation and liquor volume
assessment, there are no specific Doppler techniques to facilitate a fetus specific approach
in the management of these pregnancies. Risk assessment for an individual fetus for
intrapartum distress is therefore limited by its inherent poor specificity with current clinical
practices. Recently published studies have shown that combination of CPR in addition to
intrapartum electronic fetal heart rate monitoring is useful in the prediction of both the
intrapartum and subsequent risk of the adverse neonatal outcome.(129)Prelabour
assessment of cardiac function in addition with CPR combined with existing clinical practice
of intrapartum monitoring may help to identify fetuses at risk for appropriate obstetric
management.
Identification of fetuses that are at high or low risk of intrapartum distress by these
assessments would allow informed decisions to be made regarding the mode and the place
of delivery. Prior risk stratification of pregnancies may also allow safer allocation of women
to be delivered outside of obstetric units. This will reduce transfer rates as well as the
associated financial costs to the NHS. For example, fetuses that are classified as high risk of
developing intrapartum fetal distress may opt for elective caesarean section, reducing the
risks and costs associated with an emergency procedure, as well as the psychological and
emotional impact of emergency delivery on the woman and the partner.
Previously published reports have shown elevated levels of N -terminal peptide of the pro-
atrial natriuretic peptide (NT -pro ANP) and Cardiac Troponin-T (cTnT) in post-natal fetal
blood samples in fetuses with placental insufficiency. These fetuses also showed a change in
the distribution of the cardiac output with increased left cardiac output consistent with
175
chronic hypoxemia.(89) Similarly, another prospective cross-sectional study by Girsen et
al.(166) looked at 42 fetuses with growth restriction that had Doppler assessment of
cardiovascular hemodynamics within seven days before delivery. Fetuses with severe
growth restriction and abnormal umbilical and DV Doppler showed significantly increased
NT -pro ANP levels. These fetuses also showed a change in distribution of the cardiac output
consistent with chronic hypoxemia.
Our results have shown that prelabour assessment of cardiac function in addition to the CPR
in AGA fetuses at term can identify fetuses at risk of subsequent intrapartum fetal distress.
While the overall cardiac output was maintained, there was a significant difference in the
ratio of the right to the left cardiac output in fetuses that were delivered by emergency
caesarean section for fetal distress. Further investigation of this technique using randomised
controlled trials would be essential before considering its application in clinical practice.
176
References
1. Engineer N, Kumar S. Perinatal variables and neonatal outcomes in severely growth restricted preterm fetuses. Acta Obstet Gynecol Scand. 2010;89: 1174-81. 2. Jonsson M, Nordén-Lindeberg S, Östlund I et al. Metabolic acidosis at birth and suboptimal care – illustration of the gap between knowledge and clinical practice.BJOG. 2009;116: 1453-60. 3. Donn SM, Chiswick ML, Fanaroff JM. Medico-legal implications of hypoxic–ischemic birth injury. Semin Fetal Neonatal Med. 2014;19: 317-21. 4. Hagberg B, Hagberg G, Beckung E et al. Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991–94. Acta Paediatr. 2001;90: 271-7. 5. Kumar S, Paterson-Brown S. Obstetric aspects of hypoxic ischemic encephalopathy. Early Hum Dev. 2010;86: 339-44. 6. Himmelmann K, Uvebrant P. The panorama of cerebral palsy in Sweden. XI. Changing patterns in the birth-year period 2003–2006. Acta Paediatr. 2014;103: 618-24. 7. Alfirevic Z, Devane D, Gyte GM. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev. 2013;5: CD006066. 8. Sadler TW. Langman's essential medical embryology 2005, Lippincott Williams and Wilkins. 9. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003;69: 1-7. 10. Odibo AO, Zhong Y, Longtine M et al. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction. Placenta. 2011;32: 333-8. 11. Kovo M, Schreiber L, Ben-Haroush A et al. The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction. Prenat Diagn. 2012;32: 632-7. 12. Janbu T, Nesheim BI. Uterine artery blood velocities during contractions in pregnancy and labour related to intrauterine pressure. Br J Obstet Gynaecol. 1987;94: 1150-5. 13. Huang BY, Castillo M. Hypoxic-Ischemic Brain Injury: imaging findings from birth to adulthood. RadioGraphics. 2008;28: 417-39. 14. NICE Guidelines UK -- Intrapartum care 2014. www.nice.org.uk/guidance 15. Ananth CV, Chauhan SP, Chen HY et al. Electronic fetal monitoring in the United States: temporal trends and adverse perinatal outcomes. Obstet Gynecol. 2013;121: 927-33. 16. Williams B, Arulkumaran S. Cardiotocography and medicolegal issues. Best Pract Res Clin Obstet Gynaecol. 2004;18: 457-66.
177
17. Neilson JP. Fetal electrocardiogram (ECG) for fetal monitoring during labour. Cochrane Database Syst Rev. 2013; 5:CD000116. 18. Mahendru AA, Lees CC. Is intrapartum fetal blood sampling a gold standard diagnostic tool for fetal distress? Eur J Obstet Gynecol Reprod Biol. 2011;156: 137-9. 19. East CE, Leader LR, Sheehan P et al. Intrapartum fetal scalp lactate sampling for fetal assessment in the presence of a non-reassuring fetal heart rate trace. Cochrane Database Syst Rev. 2010;17: CD006174 . 20. Kuhnert M. Guidelines for the use of fetal pulse oximetry during labour and delivery. Prenat Neonatal Med. 1998;3: 432–3. 21. East CE, Chan FY, Colditz PB et al. Fetal pulse oximetry for fetal assessment in labour. Cochrane Database Syst Rev. 2007;18: CD004075. 22. East CE, Begg L, Colditz PB et al. Fetal pulse oximetry for fetal assessment in labour. Cochrane Database Syst Rev. 2014;10: CD004075. 23. Woo J et al. A short History of the development of Ultrasound in Obstetrics and Gynecology www.ob-ultrasound.net/history. 24. Curie. J.P. C. Développement par pression de l'é'lectricite polaire dans les cristaux hémièdres à faces inclinées. Acad Sci (Paris) 91:294. 25. Donald I, MacVicar J, Brown, TG. Investigation of abdominal masses by pulsed ultrasound. Lancet. 1958;1: 1188-1195. 26. Donald I. Clinical applications of ultrasonic techniques in obstetrical and gynaecological diagnosis. J Obstet Gynaecol Br Emp. 1962;69: 1036. 27. Bhide, Acharya G, Bilardo CM et al. ISUOG Practice Guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol. 2013;41: 233-9. 28. WFUMB Symposium on Safety of Ultrasound in Medicine.Conclusions and recommendation on thermal and non-thermal mechanisms for biological effects of ultrasound. World Federation for Ultrasound in Medicine and Biology. Ultrasound Med Biol. 1998;24: S1-58. 29. Zhu J, Lin J, Zhu Z et al. Effects of diagnostic levels of colour Doppler ultrasound energy on the cell cycle of newborn rats. J Ultrasound Med. 1999;18: 257-60. 30. Torloni MR, Vedmedovska N, Merialdi M et al. Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis. Ultrasound Obstet Gynecol. 2009;33: 599-608. 31. Bakker M, Pajkrt E, Bilardo CM. Increased nuchal translucency with normal karyotype and anomaly scan: What next? Best Pract Res Clin Obstet Gynaecol. 2014;28: 355-66. 32. Callen P.W Ultrasonography in Obstetrics and Gynaeclogy. 5th Edition;2008, Saunders Elsevier.
33. Ben-Haroush A, Yogev Y, Bar J et al. Accuracy of sonographically estimated fetal weight in 840 women with different pregnancy complications prior to induction of labor. Ultrasound Obstet Gynecol. 2004;23: 172-6. 34. Damodaram M, Story L, Kulinskaya E et al. Early adverse perinatal complications in preterm growth-restricted fetuses. Aust N Z J Obstet Gynaecol. 2011;51: 204-9. 35. Danielian PJ, Allman AC, Steer PJ. Is obstetric and neonatal outcome worse in fetuses who fail to reach their own growth potential? . Br J Obstet Gynaecol. 1992;99: 452-4. 36. Brace RA, Wolf EJ. Normal amniotic fluid volume changes throughout pregnancy. Am J Obstet Gynecol. 1989;161: 382-8. 37. Manning FA, Hill LM, Platt LD. Qualitative amniotic fluid volume determination by ultrasound: antepartum detection of intrauterine growth retardation. Am J Obstet Gynecol. 1981;139: 254-8. 38. Manning FA, Platt LD, Sipos L. Antepartum fetal evaluation: Development of a fetal biophysical profile. Am J Obstet Gynecol. 1980; 136: 787-95. 39. Chamberlain PF, Manning FA, Morrison I et al. Ultrasound evaluation of amniotic fluid volume.I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome. Am J Obstet Gynecol. 1984;150: 245-9. 40. Bar-Hava I, Divon MY, Sardo M. Is oligohydramnios in posteterm pregnancy associated with redistribution of cerebral blood flow? Am J Obstet Gynecol. 1995;173: 519-22. 41. Selam B, Koksal R, Ozcan T. Fetal arterial and venous Doppler parameters in the interpretation of oligohydramnios in postterm pregnancies. Ultrasound Obstet Gynecol. 2000;15: 403-6. 42. Ciftci AO, Tanyel FC, Ercan MT et al. In utero defecation by the normal fetus: a radionuclide study in the rabbit. J Pediatr Surg.1996;31: 1409–12. 43. Steer PJ, Eigbe F, Lissauer TJ et al. Interrelationships among abnormal cardiotocograms in labor, meconium staining of the amniotic fluid, arterial cord blood pH, and Apgar scores. Obstet Gynecol. 1989;74: 715-21. 44. Dargaville PA, Copnell B. The epidemiology of meconium aspiration syndrome: incidence, risk factors, therapies, and outcome. Pediatrics. 2006;117: 1712–21. 45. Beligere N, Rao R. Neurodevelopmental outcome of infants with meconium aspiration syndrome: report of a study and literature review. J Perinatol. 2008;28: S93-101. 46. Pariente G, Peles C, Perri ZH et al. Meconium-stained amniotic fluid - risk factors and immediate perinatal outcomes among SGA infants. J Matern Fetal Neonatal Med. 2015;28: 1064-7. 47. Nicolaides KH. Placental and fetal Doppler: The Parthenon Publishing Group; 2000. 48. Abuhamad AZ. The Role of Doppler ultrasound in Obstetrics. Ultrasonography in Obstetrics and Gynaecology 2008; 5th editon Saunders Elsevier: pages 794 -807.
179
49. Lees C, Albaiges G, Deane C et al. Assessment of umbilical arterial and venous flow using color Doppler. Ultrasound Obstet Gynecol.1999;14: 250-5. 50. Parra-Cordero M, Lees C, Missfelder-Lobos H et al. Fetal arterial and venous Doppler pulsatility index and time averaged velocity ranges. Prenatal Diagn.2007;27: 1251-7. 51. Baschat AA. Examination of the fetal cardiovascular system. Semin Fetal Neonatal Med 2011;16 :2-12. 52. Alfirevic Z, Stampalija T, Gyte GM. Fetal and umbilical Doppler ultrasound in high-risk pregnancies. Cochrane Database Syst Rev 2010;20: CD007529. 53. Ogunyemi D, Stanley R, Lynch C et al. Umbilical artery velocimetry in predicting perinatal outcome with intrapartum fetal distress. Obstet Gynecol. 1992;80: 377-80. 54. Siristatidis C, Salamalekis E, Kassanos D et al. Evaluation of fetal intrapartum hypoxia by middle cerebral and umbilical artery Doppler velocimetry with simultaneous cardiotocography and pulse oximetry. Arch Gynecol Obstet. 2004;270: 265-70. 55. Farrell T Chien PF, Gordon A. Intrapartum umbilical artery Doppler velocimetry as a predictor of adverse perinatal outcome: a systematic review. Br J Obstet Gynaecol. 1999;106: 783-92. 56. Flood K, Unterscheider J, Daly S et al. The role of brain sparing in the prediction of adverse outcomes in intrauterine growth restriction: results of the multicenter PORTO Study. Am J Obstet Gynecol. 2014;211: 288.e1-5. 57. Schenone MH, Mari G. The MCA Doppler and its role in the evaluation of fetal anemia and fetal growth restriction. Clin Perinatol. 2011;38: 83-102. 58. Harman CR, Baschat AA. Comprehensive assessment of fetal wellbeing: which Doppler tests should be performed? Curr Opin Obstet Gynecol . 2003;15: 147-57. 59. Mari G, Deter RL. Middle cerebral artery flow velocity waveforms in normal and small-for-gestational-age fetuses. Am J Obstet Gynecol. 1992;166: 1262-70. 60. Mari G, Hanif F. Fetal Doppler: Umbilical Artery, Middle Cerebral Artery, and Venous System. Semin Perinatol. 2008;32: 253-7. 61. Thornburg KL. Fetal response to intrauterine stress. Ciba Found Symp.1991;156: 17-29. 62. Wladimiroff JW, vd Wijngaard JA, Degani S et al. Cerebral and umbilical arterial blood flow velocity waveforms in normal and growth-retarded pregnancies. Obstet Gynecol. 1987;69: 705-9. 63. Arbeille P RA, Berson M, Patat F et al. Exploration of the fetal cerebral flow by duplex Doppler linear array system in normal and pathological pregnancies. Ultrasound Med Biol. 1987;13: 329-37. 64. Khalil A, Thilaganathan B. Role of uteroplacental and fetal Doppler in identifying fetal growth restriction at term. Best Pract Res Clin Obstet Gynaecol. 2017;38: 38-47.
180
65. Dunn L, Sherrell H, Kumar S. Review: Systematic review of the utility of the fetal cerebroplacental ratio measured at term for the prediction of adverse perinatal outcome. Placenta. 2017;S0143-4004: 30149-2. 66. Ebbing C, Rasmussen S, Kiserud T. Middle cerebral artery blood flow velocities and pulsatility index and the cerebroplacental pulsatility ratio: longitudinal reference ranges and terms for serial measurements. Ultrasound Obstet Gynecol. 2007;30: 287-96. 67. Bahado-Singh RO, Kovanci E, Jeffres A et al. The Doppler cerebroplacental ratio and perinatal outcome in intrauterine growth restriction. Am J Obstet Gynecol. 1999;180: 750-6. 68. Siristatidis C, Kassanos D, Salamalekis G et al. Cardiotocography alone versus cardiotocography plus Doppler evaluation of the fetal middle cerebral and umbilical artery for intrapartum fetal monitoring: a Greek prospective controlled trial. J Matern Fetal Neonatal Med. 2012;25: 1183-7. 69. Prior T, Mullins E, Bennett P et al. Prediction of intrapartum fetal compromise using the cerebroumbilical ratio: a prospective observational study. Am J Obstet Gynecol. 2013;208: 124 e1-6. 70. Tchirikov M, Rybakowski C, Hüneke B et al. Blood flow through the ductus venosus in singleton and multifetal pregnancies and in fetuses with intrauterine growth retardation. Am J Obstet Gynecol .1998;178: 943-9. 71. Tchirikov M, Schröder HJ, Hecher K. Ductus venosus shunting in the fetal venous circulation: regulatory mechanisms, diagnostic methods and medical importance. Ultrasound Obstet Gynecol 2006;27: 452-61. 72. Baschat AA. Ductus venosus Doppler for fetal surveillance in high-risk pregnancies. Clin Obstet Gynecol 2010;53: 858-68. 73. Matias A, Gomes C, Flack N et al. Screening for chromosomal abnormalities at 10–14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol. 1998;12: 380–384. 74. Maiz N, Plasencia W, Dagklis T et al. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness. Ultrasound Obstet Gynecol. 2008;31: 256–260. 75. Martınez JM, Comas M, Borrell A et al. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency. Ultrasound Obstet Gynecol. 2010;35: 267–272. 76. Borrell A, Grande M, Bennasar M et al. First-trimester detection of major cardiac defects with the use of ductus venosus blood flow. Ultrasound Obstet Gynecol. 2013;42: 51-7. 77. Maiz N, Nicolaides KH. Ductus venosus in the first trimester:contribution to screening of chromosomal, cardiac defects and monochorionic twin complications. Fetal Diagn Ther.2010;28: 65–71. 78. Crispi F, Gratacós E. Fetal cardiac function: Technical considerations and potential research and clinical applications. Fetal Diagn Ther. 2012;32: 47-64.
181
79. Crispi F, Figueras F, Cruz-Lemini M et al. Cardiovascular programming in children born small for gestational age and relationship with prenatal signs of severity. Am J Obstet Gynecol. 2012;207: 121. e1-9. 80. Crispi F, Hernandez-Andrade E, Pelsers MM et al. Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. Am J Obstet Gynecol 2008;199: 254.e1-8 81. Mielke G, Benda N. Cardiac output and central distribution of blood flow in the human fetus. Circulation. 2001;103: 1662-8. 82. Holzmann M, Cnattingius S, Nordström L. Lactate production as a response to intrapartum hypoxia in the growth-restricted fetus. BJOG. 2012;119: 1265-9. 83. Herrera EA, Camm EJ, Cross CM et al. Morphological and functional alterations in the aorta of the chronically hypoxic fetal rat. J Vasc Res. 2012: 50–8. 84. Herrera EA, Pulgar VM, Riquelme RA et al. High-altitude chronic hypoxia during gestation and after birth modifies cardiovascular responses in newborn sheep. Am J Physiol Regul Integr Comp Physiol. 2007;292: 2234-40. 85. Pulgar VM, Zhang J, Massmann GA et al. Mild chronic hypoxia modifies the fetal sheep neural and cardiovascular responses to repeated umbilical cord occlusion. Brain Res.2007;1176: 18-26. 86. Tchirikov M, Strohner M, Scholz A. Cardiac output and blood flow volume redistribution during acute maternal hypoxia in fetal sheep. J Perinat Med.2010;38: 387-92. 87. Kiserud T, Ebbing C, Kessler J et al. Fetal cardiac output, distribution to the placenta and impact of placental compromise. Ultrasound Obstet Gynecol . 2006;28: 126-36. 88. Hecher K, Campbell S, Doyle P et al. Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Arterial, intracardiac and venous blood flow velocity studies. Circulation. 1995;91: 129-38. 89. Makikallio K, Vuolteenaho O, Jouppila P et al. Ultrasonographic and biochemical markers of human fetal cardiac dysfunction in placental insufficiency. Circulation. 2002;105: 2058-63. 90. Soothill PW, Bobrow CS, Holmes R et al. Small for gestational age is not a diagnosis. Ultrasound Obstet Gynecol.1999;13: 225-8. 91. Eixarch E, Meler E, Iraola A et al. Neurodevelopmental outcome in 2-year-old infants who were small-for-gestational age term fetuses with cerebral blood flow redistribution. Ultrasound Obstet Gynecol. 2008;32: 894-9. 92. Illa M, Coloma JL, Eixarch E et al. Growth deficit in term small-for-gestational fetuses with normal umbilical artery Doppler is associated with adverse outcome. J Perinat Med. 2009;37: 48-52. 93. Figueras F, Oros D, Cruz-Martinez R et al. Neurobehavior in Term, Small-for-Gestational Age Infants With Normal Placental Function. Pediatrics. 2009;124: e934-e41.
182
94. Cruz-Martinez R, Figueras F, Hernandez-Andrade E et al. Changes in myocardial performance index and aortic isthmus and ductus venosus Doppler in term, small-for-gestational age fetuses with normal umbilical artery pulsatility index. Ultrasound Obstet Gynecol. 2011;38: 400-5. 95. Comas M, Crispi F, Cruz-Martinez R et al. Tissue Doppler echocardiographic markers of cardiac dysfunction in small-for-gestational age fetuses. Am J Obstet Gynecol . 2011;205: 57.e1-.e6. 96. Parasuraman R. Comparison of the reproducibility of 2D doppler and 3D STIC in the measurement of fetal cardiac output. Open J Obstet Gynecol. 2011;1: 163-167. 97. Hadlock FP. Sonographic estimation of fetal age and weight. Radiol Clin North Am. 1990;28: 39 -44. 98. Snijders RJ, Nicolaides KH et al. Fetal biometry at 14-40 weeks gestation. Ultrasound Obstet Gynecol. 1994;4: 34-48. 99. Chitty LS, Altman DG. Charts of fetal size : limb bones. BJOG. 2002;109: 919-29. 100. Andrews PJ, Ackerman WE, Juneja MM. Aorto caval compression in the sitting and lateral decubitus positions during extradural catheterplacement in the parturient. Can J Anaesth. 1993;40: 320-4. 101. Maulik D, Yarlagadda P, Downing G. Doppler velocimetry in Obstetrics. Obstet Gynaecol Clin North Am. 1990;17: 163-86. 102. Bewley S, Campbell S, Cooper D. Uteroplacental Doppler flow velocity waveforms in the second trimester. Br J Obstet Gynaecol. 1989;96: 1040-6. 103. Hernandez-Andrade E, Benavides-Serralde JA, Cruz-Martinez R et al. Evaluation of conventional Doppler fetal cardiac function parameters: E/A ratios, outflow tracts, and myocardial performance index. Fetal Diagn Ther. 2012;32: 22-9. 104. DeVore GR. Assessing fetal cardiac ventricular function. Semin Fetal Neonatal Med. 2005;10: 515-41. 105. Ghawi H, Gendi S, Mallula K et al. Fetal Left and Right Ventricle Myocardial Performance Index: Defining Normal Values for the Second and Third Trimesters—Single Tertiary Center Experience. Pediatr Cardiol. 2013;34: 1808-15. 106. De Smedt MC, Visser GH, Meijboom EJ. Fetal cardiac output estimated by Doppler echocardiography during mid- and late gestation. Am J Cardiol. 1987;60: 338-42. 107. NICE. Clinical guideline 55: Intrapartum care. 2007: www.nice.org.uk/guidance/cg5. 108. NICE Guideline 55: Intrapartum care. 2007: 109. Garite TJ, Dildy GA, McNamara H et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. Am J Obstet Gynecol. 2000;183: 1049-58.
183
110. Ludford I, Scheil W, Tucker G et al. Pregnancy outcomes for nulliparous women of advanced maternal age in South Australia, 1998–2008. Aust N Z J Obstet Gynaecol. 2012;52: 235-41. 111. Compendium of Maternity Statistics England,April 2015; Health and Social Care Information Centre. www.hscic.gov.uk/pubs/compmaternity. 112. Wood S, Cooper S, Ross S. Does induction of labour increase the risk of caesarean section? A
systematic review and meta-analysis of trials in women with intact membranes. BJOG. 2014;121: 674-85. 113. Nippita TA, Lee YY, Patterson JA et al. Variation in hospital caesarean section rates and obstetric outcomes among nulliparae at term: a population-based cohort study.BJOG.2015;122: 702-11. 114. Arulkumaran S, Gibb DM, Lun KC et al. The effect of parity on uterine activity in labour. Br J Obstet Gynaecol.1984;91: 843-8. 115. Davies DP, Senior N, Cole G et al. Size at birth of Asian and White Caucasian babies born in Leicester: implications for obstetric and paediatric practices. Early Hum Dev. 1982;6: 257-63. 116. Carberry AE, Gordon A, Bond DM et al. Customised versus population-based growth charts as a screening tool for detecting small for gestational age infants in low-risk pregnant women. Cochrane Database Syst Rev.2014;16: CD008549. 117. Wells JC, Sharp G, Steer PJ et al. Paternal and Maternal Influences on Differences in Birth Weight between Europeans and Indians Born in the UK. PloS One. 2013;8: e61116. 118. Zipursky AR, Park AL, Urquia ML et al. Influence of paternal and maternal ethnicity and ethnic enclaves on newborn weight. J Epidemiol Community Health. 2014;68: 942-949. 119. Akolekar R, Sarno L, Wright A et al. Fetal middle cerebral artery and umbilical artery pulsatility index: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol . 2015;45: 402-8. 120. Spencer K, Heath V, El-Sheikhah A et al. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn.2005;25: 365-9. 121. Quattrocchi T, Baviera G, Pochiero T et al. Maternal Serum PAPP-A as an Early Marker of Obstetric Complications? Fetal Diagn Ther.2015;37: 33-6. 122. Small-for-Gestational Age Fetus, Investigation and Management(Green top Guideline No.31). RCOG -UK, February 2013 www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg31. 123. Prior T, Mullins E, Bennett P et al. Are 1st-trimester beta-human chorionic gonadotrophin and pregnancy-associated plasma protein A levels predictive of intrapartum fetal compromise in a selected normal population? Aust N Z J Obstet Gynaecol. 2014;54: 600-1. 124. To WW, Chan AM, Mok KM. Use of umbilical-cerebral Doppler ratios in predicting fetal growth restriction in near-term fetuses. Aust N Z J Obstet Gynaecol. 2005;45: 130-6.
184
125. Van Wassenaer-Leemhuis AG, Marlow N, Lees C, Wolf H; TRUFFLE investigators. The association of neonatal morbidity with long-term neurological outcome in infants who were growth restricted and preterm at birth: secondary analyses from TRUFFLE (Trial of Randomized Umbilical and Fetal Flow in Europe). BJOG. 2017;10: 1111/1471-0528. 126. Kassanos D, Siristatidis C, Vitoratos N et al. The clinical significance of Doppler findings in fetal middle cerebral artery during labor. Eur J Obstet Gynecol Reprod Biol. 2003;109: 45-50. 127. Habek D, Hodek B, Herman R et al. Fetal Biophysical Profile and Cerebro-Umbilical Ratio in Assessment of Perinatal Outcome in Growth-Restricted Fetuses. Fetal Diagn Ther.2003;18: 12-6. 128. DeVore GR. The importance of the cerebroplacental ratio in the evaluation of fetal well-being in SGA and AGA fetuses. Am J Obstet Gynecol. 2015;213: 5-15. 129. Ropacka-Lesiak M, Korbelak T, Świder-Musielak J et al. Cerebroplacental ratio in prediction of adverse perinatal outcome and fetal heart rate disturbances in uncomplicated pregnancy at 40 weeks and beyond. Arch Med Sci. 2015;11: 142-8. 130. Twomey S, Flatley C, Kumar S. The association between a low cerebro-umbilical ratio at 30-34 weeks gestation, increased intrapartum operative intervention and adverse perinatal outcomes. Eur J Obstet Gynecol Reprod Biol. 2016;203: 89-93. 131. Murphy PJ. The fetal circulation. Continuing Education in Anaesthesia, Critical Care & Pain. 2005;5: 107-12. 132. Herrera EA, Camm EJ, Cross CM et al. Morphological and functional alterations in the aorta of the chronically hypoxic fetal rat. J Vasc Res. 2012;49: 50-8. 133. Weissler AM, Peeler RG, Roehll WH Jr. Relationship between LVET, stroke volume and heart rate in normal individuals and patients with cardiovascular disease. Am Heart J.1961;62: 367-78. 134. Weil SR, Russo PA, Heckman JL. Pressure-volume relationship of the fetal lamb heart. Ann Thorac Surg. 1993;55: 470-5. 135. Kirkpatrick SE, Pitlick PT, Naliboff J et al. Frank-Starling relationship as an important determinant of fetal cardiac output. Am J Physiol.1976;231: 495-500. 136. Reller MD, Morton MJ, Thornburg KL. Right ventricular function in the hypoxemic fetal sheep. J Dev Physiol. 1986;8: 159-166. 137. Alonso JG, Okai T, Longo LD et al. Cardiac function during long-term hypoxemia in fetal sheep. Am J Physiol.1989;257: H581-H589. 138. Gilbert RD. Effects of afterload and baro receptors on cardiac function in fetal sheep. JDevPhysiol. 1982;4: 299 -309. 139. Alonso JG, Okai T, Longo LD, Gilbert RD . Cardiac function during long term hypoxemia in fetal sheep. Am J Physiol.1989; 257: h581-9. 140. Adachi H, Strauss W, Ochi H et al. The effect of hypoxia on the regional distribution of cardiac output in the dog. Circ Res. 1976;39: 314-319.
185
141. Cohn HE, Piasecki GJ, Jackson BT. The effect of fetal heart rate on cardiovascular function during hypoxemia. Am J Obstet Gynecol.1980;138: 1190-9. 142. Manning FA, Platt LD, Sipos L. Antepartum fetal evaluation: development of a fetal biophysical profile. Am J Obstet Gynecol.1980; 136: 787-95. 143. Lee KA, Mi Lee S, Jin Yang H et al. The frequency of meconium-stained amniotic fluid increases as a function of the duration of labor. J Matern Fetal Neonatal Med. 2011;24: 880-885. 144. Berkus MD, Langer O, Samueloff A et al. Meconium-stained amniotic fluid: increased risk for adverse neonatal outcome. Obstet Gynecol. 1994;84: 115-120. 145. Becker S, Solomayer E, Dogan C et al. Meconium-stained amniotic fluid-perinatal outcome and obstetrical management in a low-risk suburban population. Eur J Obstet Gynecol Reprod Biol. 2007;132: 46-50. 146. Hiersch L, Krispin E, Aviram A et al. Effect of Meconium-Stained Amniotic Fluid on Perinatal Complications in Low-Risk Pregnancies at Term. Am J Perinatol. 2016;33: 378-384. 147. Malin GL, Morris RK, Khan KS. Strength of association between umbilical cord pH and perinatal and longterm outcomes: systematic review and meta-analysis BMJ.2010;13: 340: c1471. 148. Colman A, Maharaj D, Hutton J et al. Reliability of ultrasound estimation of fetal weight in term singleton pregnancies. . N Z Med J.2006;119: U2146. 149. Scioscia M, Vimercati A, Ceci O et al. Estimation of birth weight by two-dimensional ultrasonography: a critical appraisal of its accuracy. Obstet Gynecol. 2008;111: 57-65. 150. Visser GH, Ayres-de-Campos; FIGO Intrapartum Fetal Monitoring Expert Consensus Panel. FIGO consensus guidelines on intrapartum fetal monitoring:Adjunctive technologies. Int J Gynaecol Obstet. 2015;131: 25-29. 151. Rizzo G, Capponi A, Cavicchioni O et al. Fetal cardiac stroke volume determination by four-dimensional ultrasound with spatio-temporal image correlation compared with two-dimensional and Doppler ultrasonography. Prenat Diagn. 2007;27: 1147-50. 152. Molina FS, Faro C, Sotiriadis A et al. Heart stroke volume and cardiac output by four-dimensional ultrasound in normal fetuses. Ultrasound Obstet Gynecol. 2008;32: 181-7. 153. Simioni C, Nardozza LM, Araujo Júnior E et al. Heart stroke volume, cardiac output, and ejection fraction in 265 normal fetus in the second half of gestation assessed by 4D ultrasound using spatio-temporal image correlation. J Matern Fetal Neonatal Med. 2011;24: 1159-67. 154. Gardiner HM. Foetal cardiac function: assessing new technologies. Cardiol Young 2014;24: 26-35. 155. Villar J, Valladares E, Wojdyla D et al. Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet. 2006;367: 1819-29.
186
156. Althabe F, Sosa C, Belizán JM et al. Cesarean Section Rates and Maternal and Neonatal Mortality in Low-, Medium-, and High-Income Countries: An Ecological Study. Birth. 2006;33: 270-7. 157. Gibbons L. The Global Numbers and Costs of Additionally Needed and Unnecessary Caesarean Sections Performed per Year: Overuse as a Barrier to Universal Coverage. World Health Report (2010) Background Paper, 30. 158. Molina G, Weiser TG, Lipsitz SR et al. Relationship Between Cesarean Delivery Rate and Maternal and Neonatal Mortality. JAMA . 2015;314: 2263-70. 159. Liu S, Liston RM, Joseph KS et al. Maternal mortality and severe morbidity associated with low-risk planned cesarean delivery versus planned vaginal delivery at term. CMAJ. 2007;176: 455-60. 160. Lawn JE, Blencowe H, Waiswa P et al. Stillbirths: rates, risk factors, and acceleration towards 2030. Lancet. 2016;387: 587-603. 161. Birth characteristics in England and Wales 2014. www.gov.uk/government/characteristics-of-birth-1-england-and-wales-2014. 162. Bricker L, Medley N, Pratt JJ. Routine ultrasound in late pregnancy (after 24 weeks' gestation). Cochrane Database Syst Rev. 2015;29: CD 001451. 163. Sovio U, White IR, Dacey A et al. Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study. Lancet. 2015;386: 2089–2097. 164. Roma E, Arnau A, Berdala R et al. Ultrasound screening for fetal growth restriction at 36 vs 32 weeks' gestation: a randomized trial (ROUTE). Ultrasound Obstet Gynecol.2015; 46: 391-7. 165. Akolekar R, Tokunaka M, Ortega N et al. Prediction of stillbirth from maternal factors, fetal biometry and uterine artery Doppler at 19–24 weeks. Ultrasound Obstet Gynecol.2016; 48: 624-30. 166. Girsen A, Ala-Kopsala M, Mäkikallio K et al. Cardiovascular hemodynamics and umbilical artery N-terminal peptide of proB-type natriuretic peptide in human fetuses with growth restriction. Ultrasound Obstet Gynecol. 2007;29: 296-303.
Dear Dr. Paramasivam, Thank you for your email. As to your request, I am pleased to inform you that permission is granted to
use Table 1 from the article
Fetal Cardiac Function: Technical Considerations and Potential Research and Clinical Applications Crispi F. · Gratacós E. Fetal Diagn Ther 2012;32:47–64 (DOI:10.1159/000338003) to be included in your PhD thesis entitled "Ultrasound assessment of fetal cardiac function and risk of adverse obstetric and neonatal outcomes in term fetuses", provided that proper credit will be given to the original source and that S. Karger AG, Basel will be mentioned.
Please note that this is a non-exclusive permission, hence any further use, edition, translation or
distribution, either in print or electronically, requires written permission again as this permission is
valid for the above mentioned purpose only.
This permission applies only to copyrighted content that S. Karger AG owns, and not to copyrighted
content from other sources. If any material in our work appears with credit to another source, you
must also obtain permission from the original source cited in our work. All content reproduced from
copyrighted material owned by S. Karger AG remains the sole and exclusive property of S. Karger AG.
The right to grant permission to a third party is reserved solely by S. Karger AG.
Thank you for your understanding and cooperation.
Hopefully, I have been of assistance to you with the above.
APPENDICES Appendix A: Information sheet for volunteers Study title: “Ultrasound assessment of fetal cardiac function and risk of adverse obstetric and neonatal outcomes in term fetuses." Invitation to take part You are invited to participate in a research study. Before you decide, it is important for you to understand why the research is being done and what it will involve. Please take the time to read the following information. Ask us if there is anything that is not clear or if you would like more information. What is the purpose of this study? Blood flow to baby’s organs is known to change during periods of stress. These changes are particularly marked in small fetuses. Some babies become stressed during labour. We want to determine if ultrasound assessment of blood flow in the umbilical artery, brain and to the heart at the start of labour are predictive of obstetric and neonatal complications. If we have a way of identifying babies likely to become distressed in labour, it will help us better manage these pregnancies and hopefully improve the outcome for these babies. Why have I been chosen? You have been selected because you are in early labour or are likely to go into labour within 48 -72 hours. Do I have to take part? It is up to you to decide whether to participate. If you do, you will be asked to sign a consent form. If you choose not to, you will continue to receive standard management and will not affect the care you receive during the pregnancy. What will happen to me if I take part? If you decide to participate, you will be given this information sheet to keep, and we will ask you to sign a consent form. We will then perform a short ultrasound scan of your baby (lasting around 15-20 minutes). We will measure the size of your baby, amniotic fluid volume, blood flow in various vessels and fetal cardiac output. Once this is done your labour will be managed in the usual manner. The information obtained from the ultrasound scan will not be available to either the doctors or midwives looking after you. We would also take a drop of blood from your baby’s heel (heel prick test) within the first 24 hours after birth. This method of taking blood from a baby is very safe and is used routinely. You may be contacted following delivery regarding the development of the baby. All babies born to mothers recruited in this study will have heel prick samples performed at 24 hours of life to obtain dried blood spots for later analysis. Are there any side effects of obstetric ultrasound? There are no published serious side effects with antenatal ultrasound.
199
What are the possible benefits of taking part? There are no immediate benefits to you from taking part. However, the information gathered from this study may be of benefit for other pregnancies. Will my participation in this study kept confidentially? The information obtained from your study is covered by the Data Protection Act. The digital information is protected by software and hardware barrier, and the records are handled in the same way as hospital records. We also seek permission to include clinical details about your pregnancy in the study, for instance, your gestation and medical history. Who is organising the research? The Centre for Fetal Care at Queen Charlotte’s and Chelsea Hospital, Imperial College Healthcare Trust is organising this research. Who has reviewed this study? This study has been reviewed by the principal investigator and his collaborators. The London Research Ethics Committee has approved this research. What if something goes wrong? In the unlikely event of suffering adverse effects because of your participation in the study, you will be compensated through the Imperial College London's "No-fault Compensation scheme." What will happen to the results of the research study? The results from this study may be published in the medical literature. No patient's names or identifiable data will be included in the publication. Contact for Further Information Dr Gowri Paramasivam Clinical Research Fellow Centre for Fetal Care, Queen Charlotte’s and Chelsea Hospital Du Cane Road, London –W12 0HS Phone: 0208 3833998, Fax: 0208 3833507 Email: [email protected] Dr Sailesh Kumar Senior Lecturer/Consultant in Maternal and Fetal Medicine Centre for Fetal Care, Queen Charlotte’s and Chelsea Hospital Email: [email protected] Prof Phillip Bennett Consultant in Obstetrics Queen Charlotte’s and Chelsea Hospital Phone: 0208 3833998, Fax: 0208 3833507 Email: [email protected]
Appendix B Patient Consent form for inclusion in UA/MCA ratio and Fetal cardiac function assessment study. I …………………………………. have read the attached information sheet regarding the study
“Ultrasound assessment of fetal cardiac function and risk of adverse obstetric and neonatal
outcomes in term fetuses” and I would like to participate.
Signed Patient______________________________ Date______________________ Person taking Consent__________________ Date______________________
201
Appendix C Fetal Doppler/ Fetal cardiac function study Maternal Demographics Hospital Number__________ DOB___________
Age____________ Ethnicity_________ BMI____________ Smoker YES/NO Partner Yes/No Weight in Labour_______ Parity__________ Previous SB/IUGR______ Booking BP____ Raised BP in pregnancy___ Pre-existing medical condition ___________________________ Date of booking Scan ___________________________ Labour Details Spontaneous labour YES/NO Induction YES/NO If Yes Indication ___________________________ Gestation at IOL/onset of labour ____________ Membranes: Intact/Ruptured At ROM Liquor: CLEAR/MECI/MECII/MECIII Cervical Dilatation at time of USS ___________ Electronic fetal heart rate monitoring pre-labour YES/NO If Yes describe _________________________ Mode of Delivery: SVD/Forceps/Vacuum/Em.LSCS If instrumental/Em.LSCS why _____________________________ Intrapartum Hypertension YES/NO Meconium during labour YES/NO Intra-partum Pyrexia YES/NO Intrapartum Antibiotics YES/NO Associated Fetal Tachycardia YES/NO If Yes BR Rate_____________ Electronic fetal heart rate monitoring abnormalities YES/NO If yes describe___________________________________________________ FBS YES/NO Number_________ Results________________ Intrapartum haemorrhage YES/NO Intrapartum USS details Date of Scan____________
BPD HC AC
FL AFI DVP
EFW
Fetal Doppler Indices
Umbilical artery 1 2 3 MCA 1 2 3
PI PI
202
Cerebro Placental Ratio (CPR) = (MCA Pi /Umbilical artery Pi)
MCA Pi UA Pi CPR
MCA Pi UA Pi CPR
MCA Pi UA Pi CPR
Fetal Cardiac Function
Cardiac parameters 1 2 3
ICT
IRT
ET
MPI = ICT + IRT / ET
E/A Ratio Mitral valve
E/A Ratio Tricuspid valve
1 2 3 1 2 3
Heart rate at Aorta Heart rate at Pulmonary artery
Labour Outcome Date of Delivery __________ Gestation at delivery _______ Birth Weight__________ Apgar score: ____at 1m_____at 5min ______at 10 min_______ Cord Gases: pH_____ BE ______ Admission to NNU YES/NO Reason for admission ________________
Length of stay ________________ Ventilation ________________ Sepsis ________________ NEC ________________
Cranial USS/MRI ______________ Other complications ______________
203
Abbreviations FGR Fetal growth restriction
HII Hypoxic ischemic injury
ATP adenosine triphosphate
NMDA N-methyl d-aspartate
CTG Cardiotocography
bpm beats per minute
FHR Fetal heart rate
NICE National Institute for Health and Care Excellence
FBS Fetal blood sampling
ALARA As Low As Reasonably Achievable
SGA small for gestation age
MVP maximum vertical pool measurement
AFI Amniotic fluid index
MSAF Meconium stained amniotic fluid
Pi Pulsatility index
PSV Peak systolic velocity
MCA Pi Middle cerebral artery Pulsatility index
UA Pi Umbilical artery Pulsatility index
DV Ductus venosus
CPR Cerebroplacental ratio
C-U ratio cerebro-umbilical ratio
SV Stroke volume
LCO Left cardiac output
RCO Right cardiac output
CCO Combined cardiac output
MPI Myocardial performance index
EV Ejection velocity
ET Ejection time
VTI Velocity time integral
CS-FTP Emergency caesarean section for prolonged second stage of labour
CS-FD Emergency caesarean section for intrapartum fetal distress
Ins -FTP Instrumental delivery for prolonged second stage of labour
Ins -FD Instrumental delivery for intrapartum fetal distress